US.WST · West Pharmaceutical Services

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.4578879170715906,
        "turnoverUsdM": 160.77096,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.WST",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 352.23,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 4.9,
      "take_profit_price": 390.6228,
      "target_multiplier": 1.9,
      "technical_strength": 1.75,
      "take_profit_percent": 5.4
    },
    "positionPoints": 1.4,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.915775834143181,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 67.4,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 60.4,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 353.5815,
    "ma50": 350.4438,
    "close": 370.44,
    "prevClose": 373.6,
    "avgVolume20": 609865,
    "volumeRatio": 0.71,
    "changePercent": -0.85
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": 0.022439347520079478,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 0.7156284008838175,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 0.433596604103133,
      "volat_points": 0,
      "day_range_pct": 0.009961127308066078,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 67.4,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.2,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 64,
        "contribution": 3.2
      },
      {
        "raw": 10.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 54,
        "contribution": 10.8
      },
      {
        "raw": 13.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 89.33,
        "contribution": 13.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 20.8,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 69.33,
        "contribution": 20.8
      },
      {
        "raw": 3,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 30,
        "contribution": 3
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 60.4,
    "details": [
      "基本面分析總分: 3.2/5分",
      "資金流分析總分: 10.8/20分",
      "市場環境分析總分: 13.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 20.8/30分",
      "情緒分析: 3/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.2,
      "資金流": 10.8,
      "市場環境": 13.4,
      "情緒分析": 3,
      "技術信號": 20.8,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.6,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 160.77096,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 3.2,
          "obvPoints": 0.8,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.WST",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "優秀",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 14.21
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 720.8744953000001,
                "ma50": 712.6535974199999,
                "name": "QQQ",
                "close": 744.5,
                "points": 2
              },
              "spy": {
                "ma20": 765.3504968,
                "ma50": 761.5657979799997,
                "name": "SPY",
                "close": 771.34998,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.4578879170715906,
          "atrPoints": 3,
          "cciPoints": 4,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 3,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.4
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142290419,
                "url": "https://finnhub.io/api/news?id=24974cc4143032c2c8efecb139b52d007724a745d496748d647418de48bfd960",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services recently announced it will phase out a product line at its Scottsdale facility by the end of September, resulting in 98 layoffs and related manufacturing work being shifted to other Becton, Dickinson and Co. locations. At the same time, the company’s push into higher-value products and Annex 1-related sterility upgrades is being tempered by cyber incident disruptions in its West Vantage segment and tariff- and commodity-driven cost pressures. We’ll now examine...",
                "category": "company",
                "datetime": 1789931433,
                "headline": "Layoffs, Cyber Disruptions, Annex 1 Upgrades Might Change The Case For Investing In West (WST)"
              },
              {
                "id": 142289024,
                "url": "https://finnhub.io/api/news?id=22f8970c590db355c53f929db90299e6b70329479ca9d3267b1b788598511e42",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services (WST) is juggling mixed signals after recent updates on its business outlook. Investors now have to balance long-term growth drivers with fresh headwinds from a cyber incident, cost inflation, and a Scottsdale product line shutdown. Recent price action reflects that push and pull. The share price is up 9.89% over the past 90 days and 31.08% year to date, while the 1-year total shareholder return of 42.61% contrasts with a slightly negative 3-year total shareholder...",
                "category": "company",
                "datetime": 1789913264,
                "headline": "What Is Drawing Attention To West Pharmaceutical Services (WST)?"
              },
              {
                "id": 142138460,
                "url": "https://finnhub.io/api/news?id=0b9cc37aa6253e0f6bc587ae86de92bceb6cd2b0b9779a9864acd09915e8d17d",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "West Pharmaceutical Services, Inc. (WST) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 8:30 AM EDTCompany ParticipantsRobert...",
                "category": "company",
                "datetime": 1789384896,
                "headline": "West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"
              },
              {
                "id": 142061415,
                "url": "https://finnhub.io/api/news?id=47203794188e256909b52cbd8ede1931c53bea53ccc9745ad5de76c5bf889588",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "West Pharmaceutical Services, Inc. (WST) Wells Fargo 21st Annual Healthcare Conference September 10, 2026 8:45 AM EDTCompany ParticipantsRobert McMahon -...",
                "category": "company",
                "datetime": 1789037828,
                "headline": "West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141764056,
                "url": "https://finnhub.io/api/news?id=9cbab6f7eeb472c2721baa9d794caefdf1f134a429d3b369e43081e3c5e24adb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Generation Investment Management, an investment management firm, released its “Global Equity Strategy” second quarter 2026 investor letter. The letter can be downloaded here. The letter discusses the challenges of AI-driven market concentration and emphasizes the potential for long-term investors. It notes that the best companies are currently underperforming due to market returns being concentrated in […]",
                "category": "company",
                "datetime": 1788792171,
                "headline": "Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity?"
              },
              {
                "id": 141489657,
                "url": "https://finnhub.io/api/news?id=011ff4c15711d4617137fb441e555393f7c236e7aad1dd1035a302438078291e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "How West Pharmaceutical Services stock has been performing West Pharmaceutical Services (WST) has drawn investor attention after recent share price moves, with the stock closing at US$339.97 on 3 September 2026. The company shows mixed returns over different periods, including gains over the past year alongside shorter term pullbacks. For West Pharmaceutical Services, the recent 1-day share price decline of 0.81% and 3.15% share price pullback over 30 days sit against a much stronger...",
                "category": "company",
                "datetime": 1788574438,
                "headline": "West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap"
              }
            ],
            "raw_source": [
              {
                "id": 142424949,
                "url": "https://finnhub.io/api/news?id=6dbd079c7174f0bb58e0ab95c6ace326965052422fd0cba48bd7af8b47011eb1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "VEEV's AI-powered Study Builder Agent automates clinical study setup, cutting manual work while strengthening its connected Clinical Data ecosystem.",
                "category": "company",
                "datetime": 1790347980,
                "headline": "Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup"
              },
              {
                "id": 142384884,
                "url": "https://finnhub.io/api/news?id=ceec34b8e9dc244ded8d47c9b9fe42bec4e80d1aa27010705e3571f68ea8e0bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Glaukos' iDose and Epioxa are driving growth, while recurring treatments, high margins and a broad pipeline support its long-term prospects.",
                "category": "company",
                "datetime": 1790264760,
                "headline": "Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now"
              },
              {
                "id": 142363309,
                "url": "https://finnhub.io/api/news?id=af513814d32e4cbc26a7183e23bc26f43e0928eb817c7fcca6c568a3bb4d9fae",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "VEEV launches Falcon Router to automate biopharma case routing, deepening AI integration across regulated life sciences workflows.",
                "category": "company",
                "datetime": 1790182920,
                "headline": "Veeva Unveils Falcon Router to Streamline Biopharma Case Routing"
              },
              {
                "id": 142341314,
                "url": "https://finnhub.io/api/news?id=4f75cc7cf53433b2782cc4051cb1cbc802dfdadba7574d3838436620d90864fd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "iRhythm's Q2 momentum, AI-driven predictive care and deeper EHR integration support growth, though reimbursement pressures remain.",
                "category": "company",
                "datetime": 1790098080,
                "headline": "Here's Why You Should Retain IRTC Stock in Your Portfolio for Now"
              },
              {
                "id": 142339963,
                "url": "https://finnhub.io/api/news?id=e6e0e60f9535a5a4869e82a6b046dab2d8dfa4a2a70a4dfff260097ef4ee4310",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services (WST) could see earnings per share upside of at least 10% to current Wa",
                "category": "company",
                "datetime": 1790089661,
                "headline": "West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says"
              },
              {
                "id": 142328521,
                "url": "https://finnhub.io/api/news?id=fee18e15306034892ca3afc97a697bf829ff2cdb7ca4328b001fb8a29035682e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.",
                "category": "company",
                "datetime": 1790066266,
                "headline": "1 S&P 500 Stock with Exciting Potential and 2 We Ignore"
              },
              {
                "id": 142337405,
                "url": "https://finnhub.io/api/news?id=05e867d85dae2df851e09456a52b0052c99e16ecee646a6c86f362f9e4211241",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/22/Side-View-Of-Concentrated-Crypto-Trader-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "WST",
                "summary": "Analysts upgraded MetLife, Brinker, Plexus, West Pharma and Omeros, raising ratings and price targets.",
                "category": "company",
                "datetime": 1790065231,
                "headline": "This Plexus Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday"
              },
              {
                "id": 142337516,
                "url": "https://finnhub.io/api/news?id=df494fc8ad235ca8cf0523130faef4ebe9699823ea2bc734bb59fda790b60319",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "Morgan Stanley  analyst Kallum Titchmarsh   upgrades West Pharmaceutical Servs (NYSE:WST) from Equal-Weight to Overweight and raises the price target from $365 to $400.",
                "category": "company",
                "datetime": 1790058967,
                "headline": "Morgan Stanley Upgrades West Pharmaceutical Servs to Overweight, Raises Price Target to $400"
              },
              {
                "id": 142314989,
                "url": "https://finnhub.io/api/news?id=428222e8c7f43c229cac4d5fc502ce801d6f788e1a2a8b9aefc3094724a09bcc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.",
                "category": "company",
                "datetime": 1790010480,
                "headline": "Reasons to Hold Hinge Health Stock in Your Portfolio for Now"
              },
              {
                "id": 142304792,
                "url": "https://finnhub.io/api/news?id=dd4cb8cd06e2aeb921d4a787f0dda5af89135ee24a118ae74917dfda9646c209",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.",
                "category": "company",
                "datetime": 1789976065,
                "headline": "1 Surging  Stock with Solid Fundamentals and 2 That Underwhelm"
              },
              {
                "id": 142290419,
                "url": "https://finnhub.io/api/news?id=24974cc4143032c2c8efecb139b52d007724a745d496748d647418de48bfd960",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services recently announced it will phase out a product line at its Scottsdale facility by the end of September, resulting in 98 layoffs and related manufacturing work being shifted to other Becton, Dickinson and Co. locations. At the same time, the company’s push into higher-value products and Annex 1-related sterility upgrades is being tempered by cyber incident disruptions in its West Vantage segment and tariff- and commodity-driven cost pressures. We’ll now examine...",
                "category": "company",
                "datetime": 1789931433,
                "headline": "Layoffs, Cyber Disruptions, Annex 1 Upgrades Might Change The Case For Investing In West (WST)"
              },
              {
                "id": 142289024,
                "url": "https://finnhub.io/api/news?id=22f8970c590db355c53f929db90299e6b70329479ca9d3267b1b788598511e42",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services (WST) is juggling mixed signals after recent updates on its business outlook. Investors now have to balance long-term growth drivers with fresh headwinds from a cyber incident, cost inflation, and a Scottsdale product line shutdown. Recent price action reflects that push and pull. The share price is up 9.89% over the past 90 days and 31.08% year to date, while the 1-year total shareholder return of 42.61% contrasts with a slightly negative 3-year total shareholder...",
                "category": "company",
                "datetime": 1789913264,
                "headline": "What Is Drawing Attention To West Pharmaceutical Services (WST)?"
              },
              {
                "id": 142255126,
                "url": "https://finnhub.io/api/news?id=3318e305c6de73475f09a59d006f2fe7ec29a08a534d3430a37c45f73e50c4a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "AVTR expands its RIM single-use bioprocessing portfolio across APAC, boosting access to locally made solutions and supporting its bioprocessing growth push.",
                "category": "company",
                "datetime": 1789738140,
                "headline": "Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC"
              },
              {
                "id": 142255663,
                "url": "https://finnhub.io/api/news?id=89a751f98924032e33ab7f5af3cadedfc6305814452625c5b649fb432f986989",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical's biologics exposure, Annex 1 projects and delivery-device growth support prospects despite near-term headwinds.",
                "category": "company",
                "datetime": 1789737660,
                "headline": "Reasons to Add West Pharmaceutical Stock to Your Portfolio Now"
              },
              {
                "id": 142232105,
                "url": "https://finnhub.io/api/news?id=d8f933318d14ae901e29a1c72364eac42e734200c8f27bf3f18f6f9512b467ce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "BBNX's FDA-cleared Mint patch pump expands its diabetes portfolio, with a full U.S. launch planned for the first quarter of 2027.",
                "category": "company",
                "datetime": 1789660860,
                "headline": "Beta Bionics Stock Surges on FDA Clearance for Mint Patch Pump"
              },
              {
                "id": 142231517,
                "url": "https://finnhub.io/api/news?id=d2fbcf5a6ad084f6029a82395e4b80e290f082b45503961eff049d8b5a9b6b6c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.",
                "category": "company",
                "datetime": 1789660260,
                "headline": "Here's Why You Should Hold Solventum Stock in Your Portfolio for Now"
              },
              {
                "id": 142197331,
                "url": "https://finnhub.io/api/news?id=b1aafdab2fadb90ba6950ea9751e942a3c0acae727555979b9e479107ab2b853",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "AVTR's strong Q2 results, improving orders and raised 2026 outlook support growth prospects, though BMP weakness and uneven demand remain concerns.",
                "category": "company",
                "datetime": 1789573080,
                "headline": "Here's Why You Should Add Avantor Stock to Your Portfolio for Now"
              },
              {
                "id": 142197196,
                "url": "https://finnhub.io/api/news?id=31b7b9378130cf9e9c52a19433ea20bcecd6c59da8e4e6fa8575f09ed3811998",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Intuitive Surgical's CE mark expands da Vinci SP into transvaginal gynecology in Europe, opening a new women's health opportunity and growth runway.",
                "category": "company",
                "datetime": 1789573020,
                "headline": "ISRG Wins EU Nod to Expand da Vinci SP in Gynecologic Procedures"
              },
              {
                "id": 142198468,
                "url": "https://finnhub.io/api/news?id=fb8aa8441fb37538f6550400a612c2e66cdd14fbb7c4ae317d2fe41bafa45a3c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "West Pharmaceutical Services has outperformed the Nasdaq over the past year, and analysts are highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1789559408,
                "headline": "Is West Pharmaceutical Services Stock Outperforming the Nasdaq?"
              },
              {
                "id": 142166270,
                "url": "https://finnhub.io/api/news?id=124a902412c05ff547fc7b98942b8fb0474614e4ba45f9933b879f8e7e3968e0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "BTSG's specialty pharmacy, infusion and home-based care expansion support growth, while IRA and execution risks may put pressure on near-term margins.",
                "category": "company",
                "datetime": 1789485840,
                "headline": "Here's Why You Should Add BrightSpring Stock to Your Portfolio Now"
              },
              {
                "id": 142166116,
                "url": "https://finnhub.io/api/news?id=9d096852b479a00d578130a812ade2f1359c9aa90af267750b8fd8fcff2a960a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "BD expands U.S. pharmacy automation with Vmax 160 at Fairview to handle complex specialty and refrigerated medications.",
                "category": "company",
                "datetime": 1789485660,
                "headline": "BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation"
              },
              {
                "id": 142165886,
                "url": "https://finnhub.io/api/news?id=e6db18273990311a74a0f34a7a246676cffd4c2e666850929af728888f6172b8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Intuitive Surgical's da Vinci meta-analysis across 14 million procedures found better perioperative outcomes versus laparoscopic and open surgery.",
                "category": "company",
                "datetime": 1789484940,
                "headline": "ISRG's da Vinci Study Shows Better Outcomes Across 13 Common Conditions"
              },
              {
                "id": 142141667,
                "url": "https://finnhub.io/api/news?id=c8407fc472f5b8188b750160e88317d29915f29a69289864ca15585955b9537b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "DXCM's strong growth, G7 15 Day adoption and CONNECT trial could expand its CGM market opportunity despite reimbursement and competition risks.",
                "category": "company",
                "datetime": 1789411440,
                "headline": "Here's Why You Should Retain DexCom Stock in Your Portfolio for Now"
              },
              {
                "id": 142139699,
                "url": "https://finnhub.io/api/news?id=761c2f979a6724a61af01df32035c39c72f946187783426c9c079109844e1d47",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Bausch + Lomb gains European CE Mark approval for SeeLyra, expanding its surgical portfolio with a compact laser platform for cataract and corneal procedures.",
                "category": "company",
                "datetime": 1789398840,
                "headline": "BLCO Gains European CE Mark for Next-Gen SeeLyra Femtosecond Laser"
              },
              {
                "id": 142138460,
                "url": "https://finnhub.io/api/news?id=0b9cc37aa6253e0f6bc587ae86de92bceb6cd2b0b9779a9864acd09915e8d17d",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "West Pharmaceutical Services, Inc. (WST) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 8:30 AM EDTCompany ParticipantsRobert...",
                "category": "company",
                "datetime": 1789384896,
                "headline": "West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"
              },
              {
                "id": 142128337,
                "url": "https://finnhub.io/api/news?id=5407a5844cc9dd3106cdde5d4ee746a431794cfe6f78e4b1c910f36d5c7c5a45",
                "image": "",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "",
                "category": "company",
                "datetime": 1789343679,
                "headline": "Top 50 High-Quality Dividend Growth Stocks For September 2026"
              },
              {
                "id": 142087303,
                "url": "https://finnhub.io/api/news?id=ccd73376aab39d765a0ae9080eecae78d1cc12a45b23ff5dbdcee5c0d0633f93",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "RVTY's HCD deal is expected to add human pancreatic beta cell models, expanding drug discovery and preclinical research tools for metabolic diseases.",
                "category": "company",
                "datetime": 1789139940,
                "headline": "Revvity to Acquire Human Cell Design to Boost Metabolic Discovery"
              },
              {
                "id": 142085108,
                "url": "https://finnhub.io/api/news?id=bc9aa74c88bf618126826bc3780b77ec29c1cedbd9f0bbda45d92c95c37af491",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "ICCM's NMPA approval for ProSense opens China to commercialization, expanding its global regulatory footprint and long-term revenue opportunity.",
                "category": "company",
                "datetime": 1789135020,
                "headline": "IceCure Secures China NMPA Approval for ProSense Cryoablation System"
              },
              {
                "id": 142063424,
                "url": "https://finnhub.io/api/news?id=5943ebc2dcacd50994f75eab73696f0135c70c26e21548bbef5cad5ac0ed179b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "ECL benefits from high-tech growth, digital expansion, innovation and solid Q2 results, while cost fluctuations remain a key concern.",
                "category": "company",
                "datetime": 1789059420,
                "headline": "Here's Why You Should Retain Ecolab Stock in Your Portfolio Now"
              },
              {
                "id": 142062149,
                "url": "https://finnhub.io/api/news?id=29285d604f992f388ec68acaf4ef8f838d42b12c7eb5122d9655b7b3864e2ddd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Cooper Companies' Q3 EPS beats estimates as expense controls offset softer revenues, while U.S. inventory cuts pressure CooperVision and weigh on shares.",
                "category": "company",
                "datetime": 1789051500,
                "headline": "COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down"
              },
              {
                "id": 142060948,
                "url": "https://finnhub.io/api/news?id=91e437b202ec89d26d015b9e51934c0cb93f60d661336b6e85aa2aea9931c4d2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.",
                "category": "company",
                "datetime": 1789045504,
                "headline": "3 Profitable Stocks with Warning Signs"
              },
              {
                "id": 142061415,
                "url": "https://finnhub.io/api/news?id=47203794188e256909b52cbd8ede1931c53bea53ccc9745ad5de76c5bf889588",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "West Pharmaceutical Services, Inc. (WST) Wells Fargo 21st Annual Healthcare Conference September 10, 2026 8:45 AM EDTCompany ParticipantsRobert McMahon -...",
                "category": "company",
                "datetime": 1789037828,
                "headline": "West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 142026248,
                "url": "https://finnhub.io/api/news?id=3f5cd0fdb4515941bb771f71a8686240e99d400974d9617968a7b220f966a7b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "DVA gains from expanding value-based kidney care, improving dialysis volumes and clinical innovation, though payer-mix and regulatory risks persist.",
                "category": "company",
                "datetime": 1788969960,
                "headline": "Here's Why You Should Retain DaVita Stock in Your Portfolio for Now"
              },
              {
                "id": 142026249,
                "url": "https://finnhub.io/api/news?id=28203187ad70f3e286dd59081701c7678b9486a5e624ce31b8e9ec62b39d7bd5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "GEHC moves StarGuide GX closer to the U.S. market with an FDA 510(k) submission, advancing its next-generation molecular imaging push.",
                "category": "company",
                "datetime": 1788969840,
                "headline": "GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance"
              },
              {
                "id": 142030713,
                "url": "https://finnhub.io/api/news?id=66ed02d928f46f7d125966868af2c11753bf58025b2b9ea0f5186e4a588417c4",
                "image": "",
                "source": "Benzinga",
                "related": "WST",
                "summary": "UBS  analyst Doug Schenkel   maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $340 to $415.",
                "category": "company",
                "datetime": 1788962631,
                "headline": "UBS Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $415"
              },
              {
                "id": 142024974,
                "url": "https://finnhub.io/api/news?id=9a740a52835c2de44d7fd8970a806e522082652c14e6d878b5190b417fba86b0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "COO Q3 earnings are likely to benefit from CooperVision strength, improving fertility trends and efficiency gains offsetting Asia-Pacific pressure.",
                "category": "company",
                "datetime": 1788957060,
                "headline": "The Cooper Companies Gears Up to Post Q3 Earnings: What's in Store?"
              },
              {
                "id": 141951236,
                "url": "https://finnhub.io/api/news?id=fc944f8163c39e4806681686bba51fd3b2eb98f50da1f80915f260e56550b002",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "PACS plans to acquire operations of 32 Florida skilled nursing facilities, adding 4,049 licensed beds and establishing a statewide network.",
                "category": "company",
                "datetime": 1788882000,
                "headline": "PACS Expands Florida Footprint With 32-Facility Acquisition"
              },
              {
                "id": 141951237,
                "url": "https://finnhub.io/api/news?id=01256d456077114c22d008fc808213a617eecf860900f835dcdf38ba3dec3e98",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "NYXH initiates its U.S. BREATHE study with the first Genio implant, advancing long-term clinical evidence following FDA approval.",
                "category": "company",
                "datetime": 1788880620,
                "headline": "Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial"
              },
              {
                "id": 141766879,
                "url": "https://finnhub.io/api/news?id=fe2445e5a567ab197c9b5e13654a1b08bdc141906cb6c6abf6cdbf6e2265ae47",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "PHG broadens women's health ultrasound portfolio with the eV14-2v, offering enhanced imaging, a lighter design and remote collaboration.",
                "category": "company",
                "datetime": 1788798000,
                "headline": "Philips Expands Women's Health Ultrasound Portfolio With New Transducer"
              },
              {
                "id": 141765278,
                "url": "https://finnhub.io/api/news?id=edb346d008cd354b074adb4681014a1d0066be0b7dd4cb2687854eefde08fd46",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "NVCR says a cyber incident exposed limited patient and contact data, but devices stayed secure and operations remained fully functional.",
                "category": "company",
                "datetime": 1788797520,
                "headline": "Novocure Reports Patient Data Exposure in Cybersecurity Incident"
              },
              {
                "id": 141764056,
                "url": "https://finnhub.io/api/news?id=9cbab6f7eeb472c2721baa9d794caefdf1f134a429d3b369e43081e3c5e24adb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Generation Investment Management, an investment management firm, released its “Global Equity Strategy” second quarter 2026 investor letter. The letter can be downloaded here. The letter discusses the challenges of AI-driven market concentration and emphasizes the potential for long-term investors. It notes that the best companies are currently underperforming due to market returns being concentrated in […]",
                "category": "company",
                "datetime": 1788792171,
                "headline": "Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity?"
              },
              {
                "id": 141489657,
                "url": "https://finnhub.io/api/news?id=011ff4c15711d4617137fb441e555393f7c236e7aad1dd1035a302438078291e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "How West Pharmaceutical Services stock has been performing West Pharmaceutical Services (WST) has drawn investor attention after recent share price moves, with the stock closing at US$339.97 on 3 September 2026. The company shows mixed returns over different periods, including gains over the past year alongside shorter term pullbacks. For West Pharmaceutical Services, the recent 1-day share price decline of 0.81% and 3.15% share price pullback over 30 days sit against a much stronger...",
                "category": "company",
                "datetime": 1788574438,
                "headline": "West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap"
              },
              {
                "id": 141455383,
                "url": "https://finnhub.io/api/news?id=4521da65387b1edfe02b09e78249415553f3c231a03dbadecd6f07e26011f0f1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Cencora's specialty momentum, OneOncology growth and GLP-1 volumes offer upside, but drug-price cuts and MWI risks cloud its outlook.",
                "category": "company",
                "datetime": 1788550740,
                "headline": "Here's Why You Should Retain Cencora Stock in Your Portfolio for Now"
              },
              {
                "id": 141430965,
                "url": "https://finnhub.io/api/news?id=c2db62c3872d34b90c6d1100a4e38591088c4f8d82f43d7f898bd2659452d8a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "NPCE's RNS adoption, reimbursement gains, referral expansion and AI tools support growth, while IGE delays and higher spending pressure profitability.",
                "category": "company",
                "datetime": 1788533880,
                "headline": "Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now"
              },
              {
                "id": 141438250,
                "url": "https://finnhub.io/api/news?id=b32b18f70a2d6d97d3dfacec4155e52722a9bfb88b7fdbe7045235e8b9b7f072",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.",
                "category": "company",
                "datetime": 1788533460,
                "headline": "Reasons to Hold HealthEquity Stock in Your Portfolio for Now"
              },
              {
                "id": 141438251,
                "url": "https://finnhub.io/api/news?id=5312f8fd75a4bee8e63dde36cadd4968060945ef5f913769b304adbf66335ba5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "PHG's AI-powered 3D Auto CFQ shows stronger agreement with cardiac MRI than 2D PISA, supporting its cardiovascular ultrasound strategy.",
                "category": "company",
                "datetime": 1788533100,
                "headline": "Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC"
              },
              {
                "id": 141430966,
                "url": "https://finnhub.io/api/news?id=082f1e05ae3af0a526e2c1843b2f6cab5ec7e14a8c1cb1c2413f010a199696d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "COR launches CGT Enablement to help health systems build and scale cell and gene therapy programs with financial, operational and access support.",
                "category": "company",
                "datetime": 1788532620,
                "headline": "Cencora Launches Cell and Gene Therapy Enablement for Health Systems"
              },
              {
                "id": 141402952,
                "url": "https://finnhub.io/api/news?id=3d3feccc82059226879876f1951569b64ecda9577a6127905cd7eefbeb5eb152",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "VEEV's strong Q2 results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern.",
                "category": "company",
                "datetime": 1788457140,
                "headline": "Reasons to Hold Veeva Systems Stock in Your Portfolio for Now"
              },
              {
                "id": 141402704,
                "url": "https://finnhub.io/api/news?id=b3b1ef4df8c77bd564b8c103e476159f06b03899b3c6c49a40a0d45a15c635c7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "SYK's FDA-cleared SportSuite Vision brings Apple Vision Pro into hip arthroscopy, strengthening its digital surgery push and Sports Medicine portfolio.",
                "category": "company",
                "datetime": 1788457020,
                "headline": "Stryker Launches FDA-Cleared Apple Vision Pro Surgical App"
              },
              {
                "id": 141398492,
                "url": "https://finnhub.io/api/news?id=0a5a7558a4cf4b37bac18752cf142d092082b3361d51500171eb622693dad88d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Fresenius Medical's improving profitability, 5008X rollout and value-based care gains offer support despite volume and reimbursement risks.",
                "category": "company",
                "datetime": 1788441720,
                "headline": "Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now"
              },
              {
                "id": 141380177,
                "url": "https://finnhub.io/api/news?id=9111bc075f64a710a804e3e1504b76b776d99dab739d9aa15d392491ccdd05f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "HIMS has entered the second half of 2026 with weight-loss, international and AI momentum, but margin pressure and FDA uncertainty remain.",
                "category": "company",
                "datetime": 1788377400,
                "headline": "Reasons to Retain Hims & Hers Stock in Your Portfolio for Now"
              },
              {
                "id": 141380178,
                "url": "https://finnhub.io/api/news?id=2b8d1aacd8f484827e4d64710c3d4f8e5e1c531af9bc90fd4134f334d7300c3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "ENOV is set to acquire eCential Robotics to expand into orthopedic surgical robotics, though the deal is expected to pressure 2027 margins.",
                "category": "company",
                "datetime": 1788373980,
                "headline": "Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition"
              },
              {
                "id": 141379713,
                "url": "https://finnhub.io/api/news?id=86e15f8323c03c1ac87c4de0202df6bd8977a871e3b91cae624801d8ffb2b26d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "MMSI's broad portfolio, R&D investments and WRAPSODY opportunity support growth, while tariffs, China pressure and competition remain risks.",
                "category": "company",
                "datetime": 1788366660,
                "headline": "Here's Why You Should Add Merit Medical Stock to Your Portfolio Now"
              },
              {
                "id": 141379715,
                "url": "https://finnhub.io/api/news?id=2fd36efae43a9563f6f9269b884a90404cb97202438be101b33968a24fd368ef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "GE HealthCare's Photonova Spectra gains CE Mark, expanding access to its Deep Silicon photon-counting CT technology across Europe and other CE markets.",
                "category": "company",
                "datetime": 1788364440,
                "headline": "GEHC Wins CE Mark for Photonova Spectra, Expands International Reach"
              },
              {
                "id": 141376576,
                "url": "https://finnhub.io/api/news?id=3087b93c69dd0c1382b67f57ad43ee3fd98c8177a77c3279ec1cfac9960e9de0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.",
                "category": "company",
                "datetime": 1788348983,
                "headline": "1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Ignore"
              },
              {
                "id": 141370222,
                "url": "https://finnhub.io/api/news?id=cdcf9a93a89cbc3d32d6f4047a7b2d7e69a9f399531c2f750a7dc6f9b4c46f75",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.",
                "category": "company",
                "datetime": 1788281660,
                "headline": "1 Mid-Cap Stock on Our Buy List and 2 Facing Headwinds"
              },
              {
                "id": 141362435,
                "url": "https://finnhub.io/api/news?id=407196573d8a1a2c48daa3958ab0bce257f19da1b9b417899a5474c3419272a2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "SYK's planned ZuriMED acquisition adds the FiberLocker System, aiming to strengthen its shoulder portfolio and rotator cuff care capabilities.",
                "category": "company",
                "datetime": 1788275400,
                "headline": "Stryker to Acquire ZuriMED to Expand Its Shoulder Care Portfolio"
              },
              {
                "id": 141365052,
                "url": "https://finnhub.io/api/news?id=79711d7e0d41b4b20dc05cfd0d86c27dff7798c4a6e4a186ede8f489823bf6e8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "10x Genomics wins a $4.8M patent verdict against Parse, strengthening its IP position as it seeks added damages and a U.S. injunction.",
                "category": "company",
                "datetime": 1788199920,
                "headline": "TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences"
              },
              {
                "id": 141364550,
                "url": "https://finnhub.io/api/news?id=c765372856fc2104c5ca9882f08fc39c84792d17ca317ff6996861c9bc875024",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "GEHC expands its Vivid cardiovascular ultrasound portfolio with three systems featuring AI tools and cSound imaging for varied care settings.",
                "category": "company",
                "datetime": 1788190500,
                "headline": "GE HealthCare Unveils Next-Gen Vivid Cardiac Ultrasound Systems"
              },
              {
                "id": 141364000,
                "url": "https://finnhub.io/api/news?id=37a72908f114871f1a4dad46f9fc801a4f8980f63b77c0174b1008921028a865",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "CVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access to about 466,000 members across 29 states.",
                "category": "company",
                "datetime": 1787935140,
                "headline": "CVRx Secures Devoted Health Coverage for Barostim Therapy"
              },
              {
                "id": 141365055,
                "url": "https://finnhub.io/api/news?id=dc321dc028f2ca7f2718a9d3d36cde495b8ab20285726cd7afe32f57df8136c9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1787934623,
                "headline": "Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?"
              },
              {
                "id": 141365056,
                "url": "https://finnhub.io/api/news?id=5460fe93725161c219a1292541cb7aa50f6b6416a239893b11e43b8843634700",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WST",
                "summary": "NTRA teams with Angiex to use Signatera in a Phase 1 AGX101 trial, aiming to track ctDNA and deepen insights into treatment response.",
                "category": "company",
                "datetime": 1787934120,
                "headline": "Natera & Angiex Partner to Evaluate AGX101 Response With Signatera"
              },
              {
                "id": 141336283,
                "url": "https://finnhub.io/api/news?id=d92db7b94ab38deb8d45bd11ce337de7df789b48d477823807203626cf4038b8",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2215519735/image_2215519735.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "WST",
                "summary": "Dividend Aristocrats (NOBL) nearly match SPY in 2026, with top gainers, rising dividend growth, and 29 undervalued picks—see which to buy now.",
                "category": "company",
                "datetime": 1787894920,
                "headline": "Best Dividend Aristocrats For September 2026"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 6,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.4,
            "source_article_count": 63,
            "discarded_article_count": 57
          },
          "sentimentPoints": 3
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 20.8,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日4日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 558946.6666666666,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 753120,
              "avg_vol_20": 606460,
              "avg_vol_30": 558946.6666666666,
              "range_pct_10": 0.11076017708670778,
              "range_pct_20": 0.13691825936723903,
              "range_pct_30": 0.13691825936723903,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 4,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.3473915221488038,
              "dist_to_20d_high": 0.0320608040568787,
              "down_shrink_days": 1,
              "breakout_level_20d": 382.70999,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.8089511041009465
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.4578879170715906,
              "turnoverUsdM": 160.77096,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.WST",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 352.23,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 4.9,
            "take_profit_price": 390.6228,
            "target_multiplier": 1.9,
            "technical_strength": 1.75,
            "take_profit_percent": 5.4
          },
          "positionPoints": 1.4,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.915775834143181,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 9.105,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.46
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "強勢區",
      "score": 10,
      "value": 88.06
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0057
    },
    "kdj": {
      "d": 79.31,
      "j": 65.5,
      "k": 74.7,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 69.98
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": -255000,
      "recentSlope": -66720,
      "previousSlope": 109660
    },
    "rsi": 74.18,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 349.6291,
      "position": "SAR喺價下",
      "distancePct": 5.62,
      "previousTrend": "上升"
    },
    "ma50": 350.4438,
    "macd": {
      "macd": 6.537651113771744,
      "trend": "強烈看漲",
      "signal": 3.98581179846806,
      "histogram": 2.5518393153036842
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 356.0725,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 11
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.71,
      "score": 2,
      "avgVolume": 609865,
      "currentVolume": 434000
    },
    "derived": {
      "ma20": 353.5815,
      "ma50": 350.4438,
      "prevClose": 373.6,
      "avgVolume10": 742340,
      "avgVolume20": 609865,
      "changePercent": -0.85,
      "avgVolumeForScore": 609865
    },
    "ma_cross": {
      "ma20": 353.5815,
      "ma50": 350.4438,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 352.364,
      "prevMa50": 350.2838,
      "spreadPct": 0.9,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 326.2505,
      "upper": 380.9125,
      "position": "上半部"
    },
    "rsi_short": 57.89,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.71
    }
  }
}

{
  "close": 370.44,
  "volume": 434000,
  "changePercent": -0.85
}